nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—CYP2D6—Vinorelbine—ovarian cancer	0.0884	0.255	CbGbCtD
Prochlorperazine—CYP3A4—Topotecan—ovarian cancer	0.0797	0.23	CbGbCtD
Prochlorperazine—CYP3A4—Vinorelbine—ovarian cancer	0.0562	0.162	CbGbCtD
Prochlorperazine—CYP3A4—Paclitaxel—ovarian cancer	0.0395	0.114	CbGbCtD
Prochlorperazine—CYP2D6—Doxorubicin—ovarian cancer	0.0335	0.0964	CbGbCtD
Prochlorperazine—CYP3A4—Docetaxel—ovarian cancer	0.0285	0.0822	CbGbCtD
Prochlorperazine—CYP3A4—Doxorubicin—ovarian cancer	0.0213	0.0613	CbGbCtD
Prochlorperazine—Convulsion—Chlorambucil—ovarian cancer	0.00234	0.00363	CcSEcCtD
Prochlorperazine—Muscle spasms—Topotecan—ovarian cancer	0.00231	0.00359	CcSEcCtD
Prochlorperazine—Glycosuria—Epirubicin—ovarian cancer	0.00224	0.00347	CcSEcCtD
Prochlorperazine—Angioedema—Topotecan—ovarian cancer	0.0022	0.00341	CcSEcCtD
Prochlorperazine—Infection—Chlorambucil—ovarian cancer	0.00219	0.0034	CcSEcCtD
Prochlorperazine—Cardiac arrest—Paclitaxel—ovarian cancer	0.00219	0.00339	CcSEcCtD
Prochlorperazine—Blood disorder—Epirubicin—ovarian cancer	0.00217	0.00336	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00216	0.00335	CcSEcCtD
Prochlorperazine—Leukopenia—Topotecan—ovarian cancer	0.00215	0.00334	CcSEcCtD
Prochlorperazine—Liver injury—Epirubicin—ovarian cancer	0.00215	0.00334	CcSEcCtD
Prochlorperazine—Arrhythmia—Vinorelbine—ovarian cancer	0.00211	0.00328	CcSEcCtD
Prochlorperazine—Leukopenia—Melphalan—ovarian cancer	0.00211	0.00327	CcSEcCtD
Prochlorperazine—Cough—Topotecan—ovarian cancer	0.0021	0.00326	CcSEcCtD
Prochlorperazine—Glycosuria—Doxorubicin—ovarian cancer	0.00207	0.00321	CcSEcCtD
Prochlorperazine—Amenorrhoea—Epirubicin—ovarian cancer	0.00206	0.0032	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Epirubicin—ovarian cancer	0.00206	0.0032	CcSEcCtD
Prochlorperazine—Erythema—Vinorelbine—ovarian cancer	0.00206	0.00319	CcSEcCtD
Prochlorperazine—Cough—Melphalan—ovarian cancer	0.00206	0.00319	CcSEcCtD
Prochlorperazine—Convulsion—Melphalan—ovarian cancer	0.00204	0.00317	CcSEcCtD
Prochlorperazine—Blood disorder—Doxorubicin—ovarian cancer	0.00201	0.00311	CcSEcCtD
Prochlorperazine—Liver injury—Doxorubicin—ovarian cancer	0.00199	0.00309	CcSEcCtD
Prochlorperazine—Influenza—Paclitaxel—ovarian cancer	0.00199	0.00308	CcSEcCtD
Prochlorperazine—Dysphagia—Paclitaxel—ovarian cancer	0.00199	0.00308	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Topotecan—ovarian cancer	0.00196	0.00305	CcSEcCtD
Prochlorperazine—Infection—Topotecan—ovarian cancer	0.00195	0.00303	CcSEcCtD
Prochlorperazine—Dyskinesia—Epirubicin—ovarian cancer	0.00193	0.00299	CcSEcCtD
Prochlorperazine—Oedema—Melphalan—ovarian cancer	0.00192	0.00298	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Melphalan—ovarian cancer	0.00192	0.00298	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Topotecan—ovarian cancer	0.00192	0.00298	CcSEcCtD
Prochlorperazine—Infection—Melphalan—ovarian cancer	0.00191	0.00296	CcSEcCtD
Prochlorperazine—Skin disorder—Topotecan—ovarian cancer	0.00191	0.00296	CcSEcCtD
Prochlorperazine—Amenorrhoea—Doxorubicin—ovarian cancer	0.00191	0.00296	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.00191	0.00296	CcSEcCtD
Prochlorperazine—Pancytopenia—Paclitaxel—ovarian cancer	0.00189	0.00293	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Melphalan—ovarian cancer	0.00188	0.00292	CcSEcCtD
Prochlorperazine—Angioedema—Vinorelbine—ovarian cancer	0.00188	0.00292	CcSEcCtD
Prochlorperazine—Skin disorder—Melphalan—ovarian cancer	0.00187	0.0029	CcSEcCtD
Prochlorperazine—Gait disturbance—Epirubicin—ovarian cancer	0.00186	0.00288	CcSEcCtD
Prochlorperazine—Leukopenia—Vinorelbine—ovarian cancer	0.00184	0.00286	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.00181	0.00281	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Epirubicin—ovarian cancer	0.00181	0.00281	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Epirubicin—ovarian cancer	0.00181	0.00281	CcSEcCtD
Prochlorperazine—Weight increased—Paclitaxel—ovarian cancer	0.00181	0.0028	CcSEcCtD
Prochlorperazine—Hypotension—Melphalan—ovarian cancer	0.0018	0.00279	CcSEcCtD
Prochlorperazine—Cough—Vinorelbine—ovarian cancer	0.0018	0.00279	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Paclitaxel—ovarian cancer	0.00179	0.00278	CcSEcCtD
Prochlorperazine—Dermatitis contact—Epirubicin—ovarian cancer	0.00179	0.00277	CcSEcCtD
Prochlorperazine—Dyskinesia—Doxorubicin—ovarian cancer	0.00178	0.00276	CcSEcCtD
Prochlorperazine—Urticaria—Chlorambucil—ovarian cancer	0.00175	0.00272	CcSEcCtD
Prochlorperazine—Dyspnoea—Topotecan—ovarian cancer	0.00175	0.00271	CcSEcCtD
Prochlorperazine—Body temperature increased—Chlorambucil—ovarian cancer	0.00174	0.0027	CcSEcCtD
Prochlorperazine—Gait disturbance—Doxorubicin—ovarian cancer	0.00172	0.00266	CcSEcCtD
Prochlorperazine—Dyspnoea—Melphalan—ovarian cancer	0.00172	0.00266	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Epirubicin—ovarian cancer	0.0017	0.00264	CcSEcCtD
Prochlorperazine—Dysphagia—Docetaxel—ovarian cancer	0.00168	0.00261	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00168	0.0026	CcSEcCtD
Prochlorperazine—Constipation—Topotecan—ovarian cancer	0.00168	0.0026	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Doxorubicin—ovarian cancer	0.00168	0.0026	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Doxorubicin—ovarian cancer	0.00168	0.0026	CcSEcCtD
Prochlorperazine—Infection—Vinorelbine—ovarian cancer	0.00167	0.00259	CcSEcCtD
Prochlorperazine—Dermatitis contact—Doxorubicin—ovarian cancer	0.00166	0.00257	CcSEcCtD
Prochlorperazine—Coma—Epirubicin—ovarian cancer	0.00166	0.00257	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00165	0.00255	CcSEcCtD
Prochlorperazine—Skin disorder—Vinorelbine—ovarian cancer	0.00163	0.00253	CcSEcCtD
Prochlorperazine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00163	0.00252	CcSEcCtD
Prochlorperazine—Pancytopenia—Docetaxel—ovarian cancer	0.0016	0.00248	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00157	0.00244	CcSEcCtD
Prochlorperazine—Hypotension—Vinorelbine—ovarian cancer	0.00157	0.00243	CcSEcCtD
Prochlorperazine—Oedema peripheral—Paclitaxel—ovarian cancer	0.00157	0.00243	CcSEcCtD
Prochlorperazine—Pruritus—Chlorambucil—ovarian cancer	0.00156	0.00242	CcSEcCtD
Prochlorperazine—Urticaria—Topotecan—ovarian cancer	0.00156	0.00242	CcSEcCtD
Prochlorperazine—Body temperature increased—Topotecan—ovarian cancer	0.00155	0.00241	CcSEcCtD
Prochlorperazine—Weight increased—Docetaxel—ovarian cancer	0.00153	0.00238	CcSEcCtD
Prochlorperazine—Coma—Doxorubicin—ovarian cancer	0.00153	0.00237	CcSEcCtD
Prochlorperazine—Urticaria—Melphalan—ovarian cancer	0.00153	0.00237	CcSEcCtD
Prochlorperazine—Erythema multiforme—Paclitaxel—ovarian cancer	0.0015	0.00233	CcSEcCtD
Prochlorperazine—Dyspnoea—Vinorelbine—ovarian cancer	0.0015	0.00232	CcSEcCtD
Prochlorperazine—Photosensitivity—Epirubicin—ovarian cancer	0.0015	0.00232	CcSEcCtD
Prochlorperazine—Jaundice—Docetaxel—ovarian cancer	0.00146	0.00227	CcSEcCtD
Prochlorperazine—Eczema—Epirubicin—ovarian cancer	0.00146	0.00227	CcSEcCtD
Prochlorperazine—Hypersensitivity—Topotecan—ovarian cancer	0.00145	0.00224	CcSEcCtD
Prochlorperazine—Constipation—Vinorelbine—ovarian cancer	0.00144	0.00223	CcSEcCtD
Prochlorperazine—Arrhythmia—Paclitaxel—ovarian cancer	0.00142	0.0022	CcSEcCtD
Prochlorperazine—Hypersensitivity—Melphalan—ovarian cancer	0.00142	0.0022	CcSEcCtD
Prochlorperazine—Agranulocytosis—Docetaxel—ovarian cancer	0.0014	0.00217	CcSEcCtD
Prochlorperazine—Increased appetite—Epirubicin—ovarian cancer	0.0014	0.00217	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00139	0.00216	CcSEcCtD
Prochlorperazine—Pruritus—Topotecan—ovarian cancer	0.00139	0.00215	CcSEcCtD
Prochlorperazine—Photosensitivity—Doxorubicin—ovarian cancer	0.00139	0.00215	CcSEcCtD
Prochlorperazine—Erythema—Paclitaxel—ovarian cancer	0.00139	0.00215	CcSEcCtD
Prochlorperazine—Pruritus—Melphalan—ovarian cancer	0.00136	0.00211	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00136	0.00211	CcSEcCtD
Prochlorperazine—Eczema—Doxorubicin—ovarian cancer	0.00135	0.0021	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Epirubicin—ovarian cancer	0.00135	0.00209	CcSEcCtD
Prochlorperazine—Nervousness—Paclitaxel—ovarian cancer	0.00135	0.00209	CcSEcCtD
Prochlorperazine—Urticaria—Vinorelbine—ovarian cancer	0.00134	0.00207	CcSEcCtD
Prochlorperazine—Muscle spasms—Paclitaxel—ovarian cancer	0.00133	0.00206	CcSEcCtD
Prochlorperazine—Body temperature increased—Vinorelbine—ovarian cancer	0.00133	0.00206	CcSEcCtD
Prochlorperazine—Oedema peripheral—Docetaxel—ovarian cancer	0.00133	0.00206	CcSEcCtD
Prochlorperazine—Vision blurred—Paclitaxel—ovarian cancer	0.00131	0.00202	CcSEcCtD
Prochlorperazine—Dizziness—Topotecan—ovarian cancer	0.0013	0.00201	CcSEcCtD
Prochlorperazine—Tremor—Paclitaxel—ovarian cancer	0.0013	0.00201	CcSEcCtD
Prochlorperazine—Increased appetite—Doxorubicin—ovarian cancer	0.00129	0.00201	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00129	0.002	CcSEcCtD
Prochlorperazine—Erythema multiforme—Docetaxel—ovarian cancer	0.00128	0.00198	CcSEcCtD
Prochlorperazine—Agitation—Paclitaxel—ovarian cancer	0.00127	0.00197	CcSEcCtD
Prochlorperazine—Angioedema—Paclitaxel—ovarian cancer	0.00127	0.00196	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00126	0.00195	CcSEcCtD
Prochlorperazine—Cardiac arrest—Epirubicin—ovarian cancer	0.00125	0.00194	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00125	0.00193	CcSEcCtD
Prochlorperazine—Leukopenia—Paclitaxel—ovarian cancer	0.00124	0.00192	CcSEcCtD
Prochlorperazine—Rash—Topotecan—ovarian cancer	0.00124	0.00192	CcSEcCtD
Prochlorperazine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00124	0.00192	CcSEcCtD
Prochlorperazine—Dermatitis—Topotecan—ovarian cancer	0.00124	0.00192	CcSEcCtD
Prochlorperazine—Headache—Topotecan—ovarian cancer	0.00123	0.00191	CcSEcCtD
Prochlorperazine—Rash—Melphalan—ovarian cancer	0.00121	0.00188	CcSEcCtD
Prochlorperazine—Dermatitis—Melphalan—ovarian cancer	0.00121	0.00188	CcSEcCtD
Prochlorperazine—Cough—Paclitaxel—ovarian cancer	0.00121	0.00187	CcSEcCtD
Prochlorperazine—Arrhythmia—Docetaxel—ovarian cancer	0.0012	0.00187	CcSEcCtD
Prochlorperazine—Convulsion—Paclitaxel—ovarian cancer	0.0012	0.00186	CcSEcCtD
Prochlorperazine—Pruritus—Vinorelbine—ovarian cancer	0.00119	0.00184	CcSEcCtD
Prochlorperazine—Erythema—Docetaxel—ovarian cancer	0.00117	0.00182	CcSEcCtD
Prochlorperazine—Cardiac arrest—Doxorubicin—ovarian cancer	0.00116	0.00179	CcSEcCtD
Prochlorperazine—Dry mouth—Paclitaxel—ovarian cancer	0.00115	0.00179	CcSEcCtD
Prochlorperazine—Influenza—Epirubicin—ovarian cancer	0.00114	0.00176	CcSEcCtD
Prochlorperazine—Dysphagia—Epirubicin—ovarian cancer	0.00114	0.00176	CcSEcCtD
Prochlorperazine—Asthma—Epirubicin—ovarian cancer	0.00114	0.00176	CcSEcCtD
Prochlorperazine—Oedema—Paclitaxel—ovarian cancer	0.00113	0.00175	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00113	0.00175	CcSEcCtD
Prochlorperazine—Muscle spasms—Docetaxel—ovarian cancer	0.00113	0.00175	CcSEcCtD
Prochlorperazine—Eosinophilia—Epirubicin—ovarian cancer	0.00113	0.00174	CcSEcCtD
Prochlorperazine—Infection—Paclitaxel—ovarian cancer	0.00112	0.00174	CcSEcCtD
Prochlorperazine—Dizziness—Vinorelbine—ovarian cancer	0.00111	0.00172	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00111	0.00172	CcSEcCtD
Prochlorperazine—Skin disorder—Paclitaxel—ovarian cancer	0.0011	0.0017	CcSEcCtD
Prochlorperazine—Pancytopenia—Epirubicin—ovarian cancer	0.00108	0.00167	CcSEcCtD
Prochlorperazine—Rash—Vinorelbine—ovarian cancer	0.00106	0.00164	CcSEcCtD
Prochlorperazine—Dermatitis—Vinorelbine—ovarian cancer	0.00106	0.00164	CcSEcCtD
Prochlorperazine—Hypotension—Paclitaxel—ovarian cancer	0.00106	0.00164	CcSEcCtD
Prochlorperazine—Headache—Vinorelbine—ovarian cancer	0.00105	0.00163	CcSEcCtD
Prochlorperazine—Asthma—Doxorubicin—ovarian cancer	0.00105	0.00163	CcSEcCtD
Prochlorperazine—Influenza—Doxorubicin—ovarian cancer	0.00105	0.00163	CcSEcCtD
Prochlorperazine—Dysphagia—Doxorubicin—ovarian cancer	0.00105	0.00163	CcSEcCtD
Prochlorperazine—Leukopenia—Docetaxel—ovarian cancer	0.00105	0.00163	CcSEcCtD
Prochlorperazine—Eosinophilia—Doxorubicin—ovarian cancer	0.00104	0.00161	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00104	0.00161	CcSEcCtD
Prochlorperazine—Weight increased—Epirubicin—ovarian cancer	0.00103	0.0016	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Epirubicin—ovarian cancer	0.00103	0.00159	CcSEcCtD
Prochlorperazine—Cough—Docetaxel—ovarian cancer	0.00102	0.00159	CcSEcCtD
Prochlorperazine—Insomnia—Paclitaxel—ovarian cancer	0.00102	0.00158	CcSEcCtD
Prochlorperazine—Convulsion—Docetaxel—ovarian cancer	0.00102	0.00158	CcSEcCtD
Prochlorperazine—Drowsiness—Epirubicin—ovarian cancer	0.00101	0.00157	CcSEcCtD
Prochlorperazine—Clozapine—CYP1B1—ovarian cancer	0.00101	0.129	CrCbGaD
Prochlorperazine—Dyspnoea—Paclitaxel—ovarian cancer	0.00101	0.00156	CcSEcCtD
Prochlorperazine—Somnolence—Paclitaxel—ovarian cancer	0.001	0.00156	CcSEcCtD
Prochlorperazine—Pancytopenia—Doxorubicin—ovarian cancer	0.000999	0.00155	CcSEcCtD
Prochlorperazine—Jaundice—Epirubicin—ovarian cancer	0.000988	0.00153	CcSEcCtD
Prochlorperazine—Dry mouth—Docetaxel—ovarian cancer	0.000978	0.00152	CcSEcCtD
Prochlorperazine—Constipation—Paclitaxel—ovarian cancer	0.000967	0.0015	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00096	0.00149	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000958	0.00149	CcSEcCtD
Prochlorperazine—Oedema—Docetaxel—ovarian cancer	0.000958	0.00149	CcSEcCtD
Prochlorperazine—Weight increased—Doxorubicin—ovarian cancer	0.000957	0.00148	CcSEcCtD
Prochlorperazine—Infection—Docetaxel—ovarian cancer	0.000952	0.00148	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000949	0.00147	CcSEcCtD
Prochlorperazine—Agranulocytosis—Epirubicin—ovarian cancer	0.000946	0.00147	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000938	0.00145	CcSEcCtD
Prochlorperazine—Drowsiness—Doxorubicin—ovarian cancer	0.000938	0.00145	CcSEcCtD
Prochlorperazine—Skin disorder—Docetaxel—ovarian cancer	0.000931	0.00144	CcSEcCtD
Prochlorperazine—Jaundice—Doxorubicin—ovarian cancer	0.000914	0.00142	CcSEcCtD
Prochlorperazine—Urticaria—Paclitaxel—ovarian cancer	0.000898	0.00139	CcSEcCtD
Prochlorperazine—Oedema peripheral—Epirubicin—ovarian cancer	0.000896	0.00139	CcSEcCtD
Prochlorperazine—Hypotension—Docetaxel—ovarian cancer	0.000895	0.00139	CcSEcCtD
Prochlorperazine—Body temperature increased—Paclitaxel—ovarian cancer	0.000894	0.00139	CcSEcCtD
Prochlorperazine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000875	0.00136	CcSEcCtD
Prochlorperazine—Insomnia—Docetaxel—ovarian cancer	0.000867	0.00134	CcSEcCtD
Prochlorperazine—Erythema multiforme—Epirubicin—ovarian cancer	0.00086	0.00133	CcSEcCtD
Prochlorperazine—Dyspnoea—Docetaxel—ovarian cancer	0.000854	0.00132	CcSEcCtD
Prochlorperazine—Somnolence—Docetaxel—ovarian cancer	0.000852	0.00132	CcSEcCtD
Prochlorperazine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000833	0.00129	CcSEcCtD
Prochlorperazine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000829	0.00129	CcSEcCtD
Prochlorperazine—Constipation—Docetaxel—ovarian cancer	0.000819	0.00127	CcSEcCtD
Prochlorperazine—Arrhythmia—Epirubicin—ovarian cancer	0.000813	0.00126	CcSEcCtD
Prochlorperazine—Pruritus—Paclitaxel—ovarian cancer	0.0008	0.00124	CcSEcCtD
Prochlorperazine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000796	0.00123	CcSEcCtD
Prochlorperazine—Erythema—Epirubicin—ovarian cancer	0.000792	0.00123	CcSEcCtD
Prochlorperazine—Nervousness—Epirubicin—ovarian cancer	0.000769	0.00119	CcSEcCtD
Prochlorperazine—Muscle spasms—Epirubicin—ovarian cancer	0.000761	0.00118	CcSEcCtD
Prochlorperazine—Body temperature increased—Docetaxel—ovarian cancer	0.000757	0.00117	CcSEcCtD
Prochlorperazine—Arrhythmia—Doxorubicin—ovarian cancer	0.000752	0.00117	CcSEcCtD
Prochlorperazine—Dizziness—Paclitaxel—ovarian cancer	0.000748	0.00116	CcSEcCtD
Prochlorperazine—Vision blurred—Epirubicin—ovarian cancer	0.000746	0.00116	CcSEcCtD
Prochlorperazine—Erythema—Doxorubicin—ovarian cancer	0.000733	0.00114	CcSEcCtD
Prochlorperazine—Agitation—Epirubicin—ovarian cancer	0.000728	0.00113	CcSEcCtD
Prochlorperazine—Rash—Paclitaxel—ovarian cancer	0.000713	0.0011	CcSEcCtD
Prochlorperazine—Dermatitis—Paclitaxel—ovarian cancer	0.000712	0.0011	CcSEcCtD
Prochlorperazine—Nervousness—Doxorubicin—ovarian cancer	0.000712	0.0011	CcSEcCtD
Prochlorperazine—Leukopenia—Epirubicin—ovarian cancer	0.000709	0.0011	CcSEcCtD
Prochlorperazine—Headache—Paclitaxel—ovarian cancer	0.000708	0.0011	CcSEcCtD
Prochlorperazine—Hypersensitivity—Docetaxel—ovarian cancer	0.000706	0.00109	CcSEcCtD
Prochlorperazine—Muscle spasms—Doxorubicin—ovarian cancer	0.000704	0.00109	CcSEcCtD
Prochlorperazine—Domperidone—ABCB1—ovarian cancer	0.000698	0.089	CrCbGaD
Prochlorperazine—Cough—Epirubicin—ovarian cancer	0.000691	0.00107	CcSEcCtD
Prochlorperazine—Vision blurred—Doxorubicin—ovarian cancer	0.000691	0.00107	CcSEcCtD
Prochlorperazine—Convulsion—Epirubicin—ovarian cancer	0.000686	0.00106	CcSEcCtD
Prochlorperazine—Pruritus—Docetaxel—ovarian cancer	0.000678	0.00105	CcSEcCtD
Prochlorperazine—Agitation—Doxorubicin—ovarian cancer	0.000673	0.00104	CcSEcCtD
Prochlorperazine—Dry mouth—Epirubicin—ovarian cancer	0.000659	0.00102	CcSEcCtD
Prochlorperazine—Leukopenia—Doxorubicin—ovarian cancer	0.000656	0.00102	CcSEcCtD
Prochlorperazine—Oedema—Epirubicin—ovarian cancer	0.000646	0.001	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000646	0.001	CcSEcCtD
Prochlorperazine—Infection—Epirubicin—ovarian cancer	0.000642	0.000995	CcSEcCtD
Prochlorperazine—Cough—Doxorubicin—ovarian cancer	0.000639	0.000991	CcSEcCtD
Prochlorperazine—Convulsion—Doxorubicin—ovarian cancer	0.000635	0.000984	CcSEcCtD
Prochlorperazine—Dizziness—Docetaxel—ovarian cancer	0.000634	0.000982	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000633	0.000981	CcSEcCtD
Prochlorperazine—Skin disorder—Epirubicin—ovarian cancer	0.000628	0.000973	CcSEcCtD
Prochlorperazine—Dry mouth—Doxorubicin—ovarian cancer	0.00061	0.000946	CcSEcCtD
Prochlorperazine—Rash—Docetaxel—ovarian cancer	0.000604	0.000936	CcSEcCtD
Prochlorperazine—Hypotension—Epirubicin—ovarian cancer	0.000604	0.000936	CcSEcCtD
Prochlorperazine—Dermatitis—Docetaxel—ovarian cancer	0.000604	0.000936	CcSEcCtD
Prochlorperazine—Headache—Docetaxel—ovarian cancer	0.0006	0.00093	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000598	0.000927	CcSEcCtD
Prochlorperazine—Oedema—Doxorubicin—ovarian cancer	0.000598	0.000927	CcSEcCtD
Prochlorperazine—Infection—Doxorubicin—ovarian cancer	0.000594	0.000921	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000585	0.000907	CcSEcCtD
Prochlorperazine—Insomnia—Epirubicin—ovarian cancer	0.000585	0.000906	CcSEcCtD
Prochlorperazine—Skin disorder—Doxorubicin—ovarian cancer	0.000581	0.0009	CcSEcCtD
Prochlorperazine—Nefazodone—ABCB1—ovarian cancer	0.000579	0.0739	CrCbGaD
Prochlorperazine—Dyspnoea—Epirubicin—ovarian cancer	0.000576	0.000893	CcSEcCtD
Prochlorperazine—Somnolence—Epirubicin—ovarian cancer	0.000575	0.000891	CcSEcCtD
Prochlorperazine—Triflupromazine—ABCB1—ovarian cancer	0.000565	0.072	CrCbGaD
Prochlorperazine—Hypotension—Doxorubicin—ovarian cancer	0.000559	0.000866	CcSEcCtD
Prochlorperazine—Constipation—Epirubicin—ovarian cancer	0.000553	0.000857	CcSEcCtD
Prochlorperazine—Insomnia—Doxorubicin—ovarian cancer	0.000541	0.000838	CcSEcCtD
Prochlorperazine—Aripiprazole—ABCB1—ovarian cancer	0.000539	0.0687	CrCbGaD
Prochlorperazine—Trazodone—ABCB1—ovarian cancer	0.000536	0.0684	CrCbGaD
Prochlorperazine—Dyspnoea—Doxorubicin—ovarian cancer	0.000533	0.000826	CcSEcCtD
Prochlorperazine—Somnolence—Doxorubicin—ovarian cancer	0.000532	0.000824	CcSEcCtD
Prochlorperazine—Urticaria—Epirubicin—ovarian cancer	0.000513	0.000796	CcSEcCtD
Prochlorperazine—Constipation—Doxorubicin—ovarian cancer	0.000511	0.000793	CcSEcCtD
Prochlorperazine—Body temperature increased—Epirubicin—ovarian cancer	0.000511	0.000792	CcSEcCtD
Prochlorperazine—Clobazam—ABCB1—ovarian cancer	0.000502	0.0641	CrCbGaD
Prochlorperazine—Hypersensitivity—Epirubicin—ovarian cancer	0.000476	0.000738	CcSEcCtD
Prochlorperazine—Urticaria—Doxorubicin—ovarian cancer	0.000475	0.000736	CcSEcCtD
Prochlorperazine—Body temperature increased—Doxorubicin—ovarian cancer	0.000473	0.000733	CcSEcCtD
Prochlorperazine—Pruritus—Epirubicin—ovarian cancer	0.000457	0.000709	CcSEcCtD
Prochlorperazine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000441	0.000683	CcSEcCtD
Prochlorperazine—Fluphenazine—ABCB1—ovarian cancer	0.000434	0.0554	CrCbGaD
Prochlorperazine—Dizziness—Epirubicin—ovarian cancer	0.000427	0.000662	CcSEcCtD
Prochlorperazine—Pruritus—Doxorubicin—ovarian cancer	0.000423	0.000656	CcSEcCtD
Prochlorperazine—Rash—Epirubicin—ovarian cancer	0.000407	0.000632	CcSEcCtD
Prochlorperazine—Dermatitis—Epirubicin—ovarian cancer	0.000407	0.000631	CcSEcCtD
Prochlorperazine—Headache—Epirubicin—ovarian cancer	0.000405	0.000628	CcSEcCtD
Prochlorperazine—Clomipramine—ABCB1—ovarian cancer	0.000397	0.0506	CrCbGaD
Prochlorperazine—Dizziness—Doxorubicin—ovarian cancer	0.000395	0.000613	CcSEcCtD
Prochlorperazine—Chlorprothixene—ABCB1—ovarian cancer	0.000395	0.0504	CrCbGaD
Prochlorperazine—Rash—Doxorubicin—ovarian cancer	0.000377	0.000584	CcSEcCtD
Prochlorperazine—Dermatitis—Doxorubicin—ovarian cancer	0.000377	0.000584	CcSEcCtD
Prochlorperazine—Headache—Doxorubicin—ovarian cancer	0.000375	0.000581	CcSEcCtD
Prochlorperazine—Promethazine—ABCB1—ovarian cancer	0.000352	0.0449	CrCbGaD
Prochlorperazine—Trifluoperazine—ABCB1—ovarian cancer	0.000347	0.0443	CrCbGaD
Prochlorperazine—Quetiapine—ABCB1—ovarian cancer	0.000337	0.0429	CrCbGaD
Prochlorperazine—Desipramine—ABCB1—ovarian cancer	0.00032	0.0408	CrCbGaD
Prochlorperazine—Clozapine—ABCB1—ovarian cancer	0.00029	0.0369	CrCbGaD
Prochlorperazine—Chlorpromazine—ABCB1—ovarian cancer	0.000272	0.0347	CrCbGaD
Prochlorperazine—Imipramine—ABCB1—ovarian cancer	0.000271	0.0346	CrCbGaD
